PTC THERAPEUTICS, INC. — Director's Dealing 2021

Jan 15, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2021-01-13

Reporting Person: Utter Christine Marie (SVP, Finance & CAO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-13	Common Stock	S	659	$66.57	Disposed	17529	Direct
2021-01-13	Common Stock	M	788	$11.23	Acquired	18317	Direct
2021-01-13	Common Stock	S	788	$66.57	Disposed	17529	Direct
2021-01-13	Common Stock	M	2500	$18.01	Acquired	20029	Direct
2021-01-13	Common Stock	S	2500	$66.57	Disposed	17529	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-13	Stock Option (Right To Buy)	$11.23	M	788	Disposed	2027-01-02	Common Stock (788.0)	Direct
2021-01-13	Stock Option (Right to Buy)	$18.01	M	2500	Disposed	2028-01-02	Common Stock (2500)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right To Buy)	$490.8	2021-04-27	Common Stock (74.0)	74	Direct
Stock Option (Right To Buy)	$218.4	2022-01-10	Common Stock (21.0)	21	Direct
Stock Option (Right To Buy)	$40.45	2024-09-23	Common Stock (4688.0)	4688	Direct
Stock Option (Right To Buy)	$51.0	2025-01-02	Common Stock (17800.0)	17800	Direct
Stock Option (Right to Buy)	$33.02	2029-01-21	Common Stock (23907)	23907	Direct
Stock Option (Right To Buy)	$33.02	2029-01-21	Common Stock (10100.0)	10100	Direct
Stock Option (Right To Buy)	$51.16	2030-01-28	Common Stock (23800.0)	23800	Direct
Stock Option (Right to Buy)	$66.49	2031-01-05	Common Stock (50750)	50750	Direct

Footnotes

F1: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 14, 2020.

F2: Currently exercisable.

F3: This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019.

F4: This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020.

F5: This option was granted on January 22, 2019 and vests over four years, with 50% of the shares underlying the option vesting on January 22, 2022, and the remaining 50% of the original number of shares underlying the option vesting on January 22, 2023.

F6: This option was granted on January 29, 2020, and vests over four years, with 25% of the shares underlying the option vesting on January 29, 2021, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 29, 2021.

F7: This option was granted on January 6, 2021, and vests over four years, with 25% of the shares underlying the option vesting on January 6, 2022, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 6, 2022.